Composition for ameliorating side effects caused by cancer treatment comprising lactobacillus fermentum hem1036 strain as active ingredient

Abstract

A composition for ameliorating side effects of cancer treatment, comprising a strain Lactobacillus fermentum HEM1036 (KCTC13978BP) as an active ingredient according to an embodiment of the present disclosure can prevent or treat side effects caused by cancer treatment or intake of anti-cancer agents through regulation of short-chain fatty acids and modulation of gut microbiota, and the composition can be applied to food compositions, health functional food compositions, pharmaceutical compositions, etc. Under the provisions of the Budapest Treaty on the International Recognition of the Deposit of Microorganisms for the Purposes of Patent Procedure, the Lactobacillus fermentum HEM1036 strain was deposited with the international depositary authority: the Korean Collection for Type Cultures on Oct. 8, 2019, under the Accession Number: KCTC 13978BP.

Dependencies are inferred from the claim text.